Garcinol acts as an antineoplastic agent in human gastric cancer by inhibiting the PI3K/AKT signaling pathway

Gastric cancer (GC) is one of the most common malignancies worldwide; however, treatment options other than surgery remain limited. Neoadjuvant chemotherapy has the potential to suppress of gastric tumorigenesis. Garcinol has been reported to exert inhibitory effects on the progression of numerous c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yuanyuan, Guo, Chuanyong, Zhang, Xiaoping, Wang, Xiaoli, Ma, A'Huo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285879/
https://www.ncbi.nlm.nih.gov/pubmed/32565991
http://dx.doi.org/10.3892/ol.2020.11585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285879/
https://www.ncbi.nlm.nih.gov/pubmed/32565991
http://dx.doi.org/10.3892/ol.2020.11585

Ejemplares similares